Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Topical Steroid for Treatment of Postoperative Ocular Inflammation, Pain NEW YORK -- June 24, 2008 -- The US Food and Drug Administration (FDA) has approved difluprednate ophthalmic emulsion (Durezol) 0.05%, a topical steroid for the treatment of postoperative ocular inflammation and pain. The approval came after a 6 month priority review. Two phase 3 trials evaluated the safety and efficacy of difluprednate ophthalmic emulsion compared to placebo after intraocular surgery. The studies included 438 patients who presented with significant inflammation as evidenced by an anterior chamber cell grade 2 or higher the day after surgery. Patients were given a dosage of either BID or QID beginning 24 hours after intraocular surgery. Both regimens (BID and QID) had similar overall efficacy in the reduction of anterior chamber cells 2 weeks following surgery (86% in BID, 87% in QID). The QID regimen had a small numerical advantage in the number of patients who were completely free of inflammation and pain at the 1-week time point. Because of this numerical advantage, and the desire to treat inflammation aggressively, the QID dosing regimen was chosen for recommendation to doctors. Difluprednate ophthalmic emulsion was well tolerated with few treatment-related adverse events. One of the most common side effects seen with steroids in ophthalmic use is a rise in mean intraocular pressure (IOP). Three percent of patients in each of the BID and QID groups, and 1% of patients in the placebo group met the criterion for a clinically significant rise in IOP. SOURCE: Sirion Therapeutics E-mail this page to a friend or colleague! To print, use this version